Literature DB >> 9290948

FHIT gene and the FRA3B region are not involved in the genetics of renal cell carcinomas.

P Bugert1, M Wilhelm, G Kovacs.   

Abstract

The FHIT gene locus at 3p14.2 covers about 500 kb, including the fragile site FRA3B and the constitutional t(3;8) breakpoint associated with the development of multiple renal cell carcinomas (RCC). A terminal deletion of the short arm of chromosome 3 with the most distal breakpoint in the FRA3B region is the characteristic genetic event in nonpapillary RCC. Since aberrant FHIT transcripts have been observed in gastrointestinal and other tumors, this gene has been suggested to function as a tumor suppressor. To evaluate the role of FHIT and the FRA3B region in the genetics of RCC, we analyzed FHIT expression by RT-PCR and performed microsatellite deletion mapping in the FHIT region. In addition to two cases from a t(3;8) family, only three out of 100 sporadic nonpapillary RCC showed a breakpoint within the FHIT region, whereas 94 tumors showed a deletion breakpoint proximal to the FHIT gene. FHIT transcripts of normal size were observed in 33 out of 34 tumors. Direct sequencing of eight PCR products revealed a normal FHIT sequence without mutations in the coding region. An established cell line from a renal cancer xenograft showed a smaller FHIT transcript. Sequence analysis revealed a mixture of several splicing variants of the FHIT gene. Since only three out of 100 sporadic nonpapillary RCC had a deletion breakpoint within the FRA3B/FHIT region, and since all but one renal cell tumor showed a normal FHIT transcript, we can exclude the involvement of the FHIT gene and the FRA3B region in the genetics of renal cell cancer.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9290948

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  6 in total

1.  Association of a novel constitutional translocation t(1q;3q) with familial renal cell carcinoma.

Authors:  H Kanayama ; W O Lui; M Takahashi; T Naroda; D Kedra; F K Wong; Y Kuroki; Y Nakahori; C Larsson; S Kagawa; B T Teh
Journal:  J Med Genet       Date:  2001-03       Impact factor: 6.318

2.  Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.

Authors:  E R Woodward; S C Clifford; D Astuti; N A Affara; E R Maher
Journal:  J Med Genet       Date:  2000-05       Impact factor: 6.318

3.  The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8.

Authors:  R M Gemmill; J D West; F Boldog; N Tanaka; L J Robinson; D I Smith; F Li; H A Drabkin
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

Review 4.  Fragile histidine triad protein: structure, function, and its association with tumorogenesis.

Authors:  Md Imtaiyaz Hassan; Abdullah Naiyer; Faizan Ahmad
Journal:  J Cancer Res Clin Oncol       Date:  2009-12-24       Impact factor: 4.553

5.  Investigation of recurrent deletion loci specific to conventional renal cell carcinoma by comparative allelotyping in major epithelial carcinomas.

Authors:  Rashmi R Bhat Singh; Pratibha S Amare Kadam
Journal:  Indian J Urol       Date:  2012-01

6.  FHIT overexpression in HepG2 hepatoma cells affects growth and cyclin D1 expression in vitro.

Authors:  Jiayun Ge; Simin Shen; Xiaowen Zhang; Kun Wang; Bo Liu; Deyun Sun; Lin Wang
Journal:  Exp Ther Med       Date:  2013-12-04       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.